Cosmetics Act (No.2), B.E. 2565 (2022)

Re: Rules, procedures and conditions for preparation of reports on medical device malfunctions or adverse events occurring to consumers and reports on field safety corrective actions for medical devices, B.E. 2563 (2020)

Notification of the Food and Drug Administration Re: Guidelines for the Consideration of Applications for Modern Drug Registrations Submitted through Electronic Means (No.2)